ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSelling/general/admin expenses43.37 M40.02 M38.56 M39 M41.67 M159.26 MResearch & development23.43 M15.08 M21.74 M21.07 M13.55 M71.43 MOperating income-20.05 M-16.7 M-12.45 M-13.89 M-25.54 M-68.58 MNon-Operating Income, Total5.11 M5.07 M4.59 M4.1 M3.98 M17.74 MInterest expense, net of interest capitalized8.71 M8.2 M8.52 M8.64 M7.3 M32.66 MNon-Operating Income, excl. Interest Expenses-3.55 M-3.05 M-3.86 M-4.38 M-3.25 M-14.54 MUnusual income/expense-48 K-83 K-61 K-161 K-70 K-375 KPretax income-174.52 M-19.84 M-16.38 M-18.43 M-83.42 M-138.06 MEquity in earnings——————Taxes————-9.22 M—Non-controlling/minority interest——————After tax other income/expense——————Net income before discontinued operations-25.35 M-19.84 M-16.38 M-18.43 M-28.86 M-83.5 MDiscontinued operations——————Net income-25.35 M-19.84 M-16.38 M-18.43 M-28.86 M-83.5 MDilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders-25.35 M-19.84 M-16.38 M-18.43 M-28.86 M-83.5 MBasic earnings per share (Basic EPS)-0.04-0.03-0.02-0.03-0.05-0.13Diluted earnings per share (Diluted EPS)-0.04-0.03-0.02-0.03-0.05-0.13Average basic shares outstanding646.03 M665.91 M666.17 M667.1 M666.66 M2.67 BDiluted shares outstanding646.03 M665.91 M666.17 M667.1 M666.66 M2.67 BEBITDA—-18.66 M-13.93 M-15.14 M——EBIT—-16.7 M-12.45 M-13.89 M——Cost of revenue——————Other cost of goods sold——————Depreciation & amortization (cash flow)-7.4 M-1.96 M-1.48 M-1.26 M-1.16 M-5.85 M
Geron Corporation
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.